← Back to Search

PReDAS intervention for Stroke

N/A
Recruiting
Led By Liliana Alvarez, PhD
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at enrollment and end of month 1,2,3,4,5 and 6
Awards & highlights

Study Summary

This trial aims to provide Occupational Therapists (OTs) with a resource called the Practice Resource for Driving After Stroke (PReDAS) to help them address driving concerns with patients who have

Who is the study for?
This trial is for Occupational Therapists (OTs) working in acute stroke settings. It aims to help them address driving capabilities with patients who have had a stroke. The study focuses on OTs who need evidence-based resources to improve their discussions and recommendations about whether these patients can safely resume driving.Check my eligibility
What is being tested?
The intervention being tested is the Practice Resource for Driving After Stroke (PReDAS), an evidence-based guide designed to support OTs. The study will measure if PReDAS increases OT's confidence and clinical reasoning when helping stroke survivors make decisions about returning to driving.See study design
What are the potential side effects?
Since this trial involves educational resources rather than medical or pharmaceutical interventions, there are no direct physical side effects expected from participating in this research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at enrollment and end of month 1,2,3,4,5 and 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at enrollment and end of month 1,2,3,4,5 and 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
clinical reasoning
self-efficacy

Trial Design

1Treatment groups
Experimental Treatment
Group I: PReDAS interventionExperimental Treatment1 Intervention
All participants will receive the PReDAS intervention during the study. As per concurrent multiple baseline designs, each participant will be randomized as to WHEN they receive the PReDAS during the 6 month study period. Baseline lengths will vary from 2 to 5 months.

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
239 Previous Clinical Trials
56,913 Total Patients Enrolled
4 Trials studying Stroke
603 Patients Enrolled for Stroke
Liliana Alvarez, PhDPrincipal InvestigatorWestern University
1 Previous Clinical Trials
22 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this study currently open?

"Yes, as per clinicaltrials.gov data, this particular trial is actively seeking individuals to participate. The study was first made public on February 1st, 2024, and underwent its last revision on March 4th of the same year. This investigation aims to enroll a total of 8 patients from one designated site."

Answered by AI

How many individuals are anticipated to participate in this research?

"Indeed, the details on clinicaltrials.gov affirm that this investigation is presently seeking candidates. The trial was initially disclosed on February 1st, 2024 and most recently revised on March 4th, 2024. Enrollment aims to include 8 participants from a single site."

Answered by AI
~3 spots leftby Jul 2024